Drexel Morgan & Co’s Pfizer PFE Stock Holding History

Drexel Morgan & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,784	Closed	-$238K	–	90
2019 Q2	$238K	Hold	5,784	–	–	0.18%	82
2019 Q1	$233K	Hold	5,784	–	–	0.21%	84
2018 Q4	$239K	Hold	5,784	–	–	0.24%	81
2018 Q3	$242K	Hold	5,784	–	–	0.21%	83
2018 Q2	$200K	Buy	+5,784	New	+$198K	0.2%	86
2016 Q4	–	Sell	-8,118	Closed	-$261K	–	97
2016 Q3	$261K	Hold	8,118	–	–	0.29%	76
2016 Q2	$271K	Hold	8,118	–	–	0.31%	78
2016 Q1	$228K	Hold	8,118	–	–	0.27%	78
2015 Q4	$249K	Hold	8,118	–	–	0.28%	81
2015 Q3	$242K	Sell	8,118 -1,212	-13%	-$38.9K	0.31%	72
2015 Q2	$297K	Sell	9,330 -2,674	-22%	-$87.1K	0.35%	72
2015 Q1	$397K	Buy	12,004 +5,105	+74%	+$162K	0.42%	66
2014 Q4	$204K	Buy	+6,899	New	+$198K	0.23%	88
2014 Q2	–	Sell	-6,899	Closed	-$210K	–	88
2014 Q1	$210K	Buy	+6,899	New	+$206K	0.27%	79
2013 Q4	–	Sell	-6,657	Closed	-$181K	–	89
2013 Q3	$181K	Buy	+6,657	New	+$181K	0.25%	83

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Drexel Morgan & Co's PFE Position: Q3 2019 in Review

Drexel Morgan & Co sold out of Pfizer (PFE) in Q3 2019, closing a stake of 5,784 shares — an estimated $238K sold.

Drexel Morgan & Co first reported a position in PFE in Q3 2013 and held it in 15 quarters. The position peaked at $397K in Q1 2015. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

Drexel Morgan & Co reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
Drexel Morgan & Co sold 5,784 Pfizer shares in Q3 2019, an estimated $238K.
Drexel Morgan & Co first reported a position in Pfizer in Q3 2013 and held it in 15 quarters.
Drexel Morgan & Co's Pfizer position peaked at $397K in Q1 2015.
2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Drexel Morgan & Co's 13F filing for Q3 2019, filed 13 Nov 2019.